These findings are consistent with previous studies, in which the administration of BBR suppressed the secretion of IL-1, IL-1β, IL-6, IL-12, TNF-α, TGF-β and IFN-γ in a DSS-induced ulcerative colitis rat model [26]. This evidence concerns the gene TGFB1 and ulcerative colitis.